Michael G. Grey, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 50,000 shares at $78.00 ($3.9M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Scheduled sale ($3.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |
| MIRM | SELL | 2023-05-04 | $409K | — | Filing → |